Competitive Advantages
- Will enable early detection of cancer
- Combined therapy and diagnosis of various cancers and related disorders
- Specific targeted treatment to cancer cells
- Controlled release of drug
Summary
USF inventors have developed graphene quantum dot nanoparticles for cancer diagnosis and therapy. Attaching cancer-targeting drugs to the nanoparticles enables small tumor detection, real-time drug imaging, and the release of drugs when radiation is used. These advantages make the novel nanoparticles a promising strategy for the early detection of cancer, simultaneous monitoring of the drug in the body, and specific targeted treatment with minimal toxicity of the drug to healthy cells. The innovative and fast synthesis method used by our inventors to produce the nanoparticles will further expand on existing strategies to treat cancer.
Graph of Cellular Apoptosis Quantified by Flow Cytometric Analysis Exhibiting Late, Early, and Total Apoptosis
Desired Partnerships
- License
- Sponsored Research
- Co-Development